Sonya VanPatten

4PUBLICATIONS
12CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Proteins and peptidesPharmaceutical delivery technologiesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 24, 2025
Protease-Resistant Azapeptide GLP-1 Analogue Improves Metabolic Control in Diet-Induced Obesity.

Mingzhu He, Kai Fan Cheng, Sonya VanPatten

|Nov 28, 2022
Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates.

Ahmad Altiti, Mingzhu He, Sonya VanPatten

|Jul 17, 2020
Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics.

Sonya VanPatten, Mingzhu He, Ahmad Altiti

|Dec 22, 2017
High Mobility Group Box-1 (HMGb1): Current Wisdom and Advancement as a Potential Drug Target.

Sonya VanPatten, Yousef Al-Abed

Pageof 1